Solventum Corporation (SOLV)

Medical, dental and health software, 20,000 employees. Read October 19, 2026 from the annual report for the period ending December 31, 2025, filed February 27, 2026. Ranked 42 of the 95 Healthcare companies read so far, by the share within reach now.

Solventum states approximately 20,000 employees, 10,000 of them in the United States and 2,000 in Germany, 4,000 in production and 2,000 in research and development, across medical, dental and health information software businesses with no count by segment, so the product plants take most of the workforce and the software business the rest by description (c).

The figures on this page come from the company's own annual report and from BLS staffing patterns for its industries, never from a roster. They are estimates with a stated method. Nothing here says what the company will do: within reach is not a forecast of jobs lost or of savings.

What follows from the reading

Share of working time within reach of AI, on the long-run pace at four in five: 20% now, 36% at the end of 2027, 43% at the end of 2028, 45% at the end of 2030. By the patterns, the work is about 45% desk work, 17% people work and 38% body work. These are the site's industry estimates weighted by the shares below: estimates with a stated method and range, not a forecast of what the company will do. By the same patterns, at the end of 2028 about 51% of the working time stays with people (conversation, in-person and hands-on work), 39% becomes checking a model's work and 7% could be handed over with lighter checks, from the industries' own figures, not the company's roles.

Headcount

20,000 employees as of December 31, 2025 (stated). The filing states approximately 10,000 of 20,000 employees in the United States (50%) and 2,000 in Germany.

The filing: “Our employee base consists of approximately 20,000 employees, with approximately 40% having more than 10 years of tenure. We have approximately 10,000 employees in the United States and approximately 2,000 in Germany.”

The workforce as industry patterns

What the filing says about the workforce: Approximately 20,000 employees, 10,000 in the United States and 2,000 in Germany; about 4,000 production employees in plants across the globe; about 2,000 in research and development; 40% with more than 10 years of tenure.

Companies read with the same leading pattern

Other companies whose largest staffing pattern is also Medical Equipment and Supplies Manufacturing, largest first, each read from its own annual report. Within reach now and at the end of 2028, long-run pace, four in five.

• Abbott Laboratories (ABT, 115,000 employees)18% now, 35% by 2028
• Becton, Dickinson and Company (BDX, 72,000 employees)19% now, 36% by 2028
• Boston Scientific Corporation (BSX, 59,000 employees)19% now, 42% by 2028
• Stryker Corporation (SYK, 56,000 employees)19% now, 39% by 2028
• Baxter International Inc. (BAX, 37,500 employees)19% now, 37% by 2028
• Align Technology, Inc. (ALGN, 20,290 employees)19% now, 36% by 2028
• STERIS plc (STE, 17,937 employees)22% now, 39% by 2028
• Intuitive Surgical, Inc. (ISRG, 17,021 employees)21% now, 41% by 2028

What the filing says about AI

17 sentences in the filing name AI. The filing names the deployment of AI, machine learning and emerging technologies in its products and services, including in research and development, and AI regulation among its compliance areas.

• “The deployment of artificial intelligence or other emerging technologies in Solventum's products and services, or a failure to adapt its products and services, could affect future results.”
• “In addition, Solventum is subject to other complex and varying regulations related to anti-trust, anti-corruption, export control, privacy and data protection, emerging technologies, such as AI, and other areas.”
• “The deployment and use of artificial intelligence ( " AI " ), machine learning, or other emerging technologies in Solventum's products and services, including as part of its research and development efforts, or its failure to adapt its products or services to industry trends and developments related to such technologies in a timely manner, or at all, could adversely affect Solventum's business,...”
• “Solventum has begun to deploy AI in its products and services, including as part of its research and development efforts, and Solventum expects to continue to explore additional uses as AI continues to develop.”
• “For example, Solventum has incorporated AI into certain products in the Health Information Systems business segment and certain of its digital offerings and expects to continue to build AI into additional products.”

Its annual reports, year by year

Sentences naming AI in each annual report, counted by one rule, beside the median report in the Index that year. Each count links its filing. Every company, by year and sector

• Fiscal 20242median 4
• Fiscal 202517median 10

Headcount by filing year

As reported in each year's annual report, with the filing. A year marked not read had no figure the reading could take from the report's text.

Limits of this reading

• The universe's count was the U.S. 10,000; the filing states approximately 20,000 employees in all (rule 2).
• No count by segment: the split is by description (c); the data service's segment table is one line.

Source: the company's annual report on EDGAR, accession 0001964738-26-000007, the filing. Read by Claude Fable 5.1 under rubric version 1, by the method. A company can write to info@stratussc.com to have its reading checked against its filing.